Veenat (imatinib) 100 mg 120 caps. NATCO, India
Interchangeable drugs with the same active ingredient:
Alvotinib
Vinat
Vinat 100
Vinat-100-Health
Glivec
Imatib
Imatinib Actavis
Imatinib Grindeks
Imatinib Zentiva
Imatinib Medak
Imatinib-Teva
Myelofar
neopax
Indications:
treatment of patients (adults and children) with newly diagnosed chronic myeloid leukemia;
treatment of patients (adults and children) with chronic myeloid leukemia in the blast crisis phase and the acceleration phase and in the chronic phase after unsuccessful therapy with interferon alfa;
treatment of adult patients with newly diagnosed positive (with the presence in the leukocytes of the Philadelphia chromosome (bcr-abl) acute lymphoblastic leukemia as part of chemotherapy;
treatment of adult patients with acute lymphoblastic leukemia in the stage of relapse or with persistent tolerance to chemotherapy as monotherapy;
treatment of adult patients with myelodysplastic / myeloproliferative diseases associated with platelet growth factor receptor activation;
treatment of adult patients with systemic mastocytosis in the absence of D816B c-Kit mutations or in the absence of data on the mutational status of c-Kit;
treatment of adults with hypereosinophilic syndrome and / or chronic ezosinophilic leukemia;
treatment of adult patients with Kit (CD117) positive inoperable and / or metastatic malignant tumors of the stroma of the digestive tract
treatment of patients with unresectable and / or metastatic dermatofibrosarcoma.
-
Commercial name:Veenat
-
Сhemical name:Imatinib
-
Dosage:100 mg
-
Quantity:120
-
Release form:Capsules
-
Виробник:Индия